Drug-induced Parkinsonism

• FDA approval · 2023-07-03
  FDA Approved: BENZTROPINE MESYLATE — Supplemental Application (Fresenius Kabi USA, LLC)

  The FDA approved a supplemental application for benztropine mesylate, submitted by Fresenius Kabi USA, LLC.

• FDA approval · 2009-07-28
  FDA Approved: BENZTROPINE MESYLATE — Original Application (Fresenius Kabi USA, LLC)

  FDA approved the original application for benztropine mesylate (generic) by Fresenius Kabi USA, LLC, expanding access to treatment for Parki…

• FDA approval · 2007-08-27
  FDA Approved: BENZTROPINE MESYLATE — Original Application (Endo USA, Inc.)

  FDA approves Endo USA's benztropine mesylate as a generic drug under Original Application (ANDA 040715) to treat Parkinson's disease and dru…